Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 19, 2012

JSR Teams with BIA to Develop and Market Purification Systems

  • JSR and BIA Separations entered a partnership that includes JSR taking a minor equity position on November 14, 2011. The companies started a joint global marketing and sales effort as well as collaborative R&D activities in the area of downstream purification to aid in the manufacture of vaccines, DNA, and antibody-based medicines.

    Through this arrangement JSR gains access to BIA Separations’ downstream purification technology. BIA’s technology will be combined with JSR’s Protein A media. BIA expects JSR’s global presence and expertise in the field of consistent high-quality volume manufacturing will help it successfully grow its business.

    JSR is headquartered in Tokyo and has factories and offices in Europe, the U.S., China, Taiwan, Korea, and Singapore. BIA Separations claims to be the only worldwide developer and manufacturer of CIM Convective Interaction Media®, short monolithic chromatographic columns optimized for the separation and purification of large biomolecules and viral particles on the laboratory and industrial scale.

Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »